TABLE OF CONTENTS 
CALL TO ORDER: 
Dr. Walters 1 
DISCUSSION OF PROPOSED ADDITION TO APPENDIX D OF THE NIH 
GUIDELINES REGARDING HUM2^ GENE THERAPY PROTOCOL ENTITLED 
TREATMENT OF SEVERE COMBINED IMMUNODEFICIENCY DISEASE (SCID) 
DUE TO ADENOSINE DEAMINASE DEFICIENCY WITH AUTOLOGOUS 
LYMPHOCYTES TRANSDUCED WITH A HUMAN ADA GENE: 
Dr . Parkman 1 
DISCUSSION OF PROPOSED ADDITION TO APPENDIX D OF THE NIH 
GUIDELINES REGARDING HUMAN GENE THERAPY PROTOCOL ENTITLED 
GENE THERAPY OF PATIENTS WITH ADVANCED CANCER USING TUMOR 
INFILTRATING LYMPHOCYTES TRANSDUCED WITH THE GENE CODING 
FOR TUMOR NECROSIS FACTOR: 
Dr. Mclvor 18 
PROPOSED ADDITION TO APPENDIX D OF THE NIH GUIDELINES 
REGARDING HUMAN GENE TRANSFER CLINICAL PROTOCOL ENTITLED 
USE OF MARKER GENES TO INVESTIGATE THE BIOLOGY OF MARROW 
RECONSTITUTION AND RELAPSE OF MALIGNANT DISEASE FOLLOWING 
AUTOLOGOUS BONE MARROW TRANSPLANTATION: 
Dr. Leventhal 35 
ADJOURNMENT: 
Dr. Walters 45 
Recombinant DNA Research, Volume 14 
[ 55 ] 
